Long-acting Etonogestrel Microspheres

Product Overview

Delivery Type: ,

Description: Orbis Biosciences is developing a 6-month injectable microsphere formulation containing etonogestrel using Orbis Biosciences' patented Precision Particle Fabrication (PPF) technology for achieving uniform particle size.

Updated date: May 30, 2018

Vertical Tabs

Status

Began discovery in: 2013

Download Product Report